Gene · 4070
Papers3,230
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,230
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer. | Front Oncol | 2023 | 37469398 | PubTator, text mining | PubMed |
| Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure. | ESMO Open | 2023 | 37467660 | PubTator, text mining | PubMed |
| Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer. | Front Cell Dev Biol | 2023 | 37457288 | PubTator, text mining | PubMed |
| A non-mutated TROP2 fingerprint in cancer genetics. | Front Oncol | 2023 | 37456256 | PubTator, text mining | PubMed |
| Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions. | J Transl Med | 2023 | 37452395 | PubTator, text mining | PubMed |
| Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. | Int J Mol Sci | 2023 | 37446085 | PubTator, text mining | PubMed |
| Advances in PET/CT Imaging for Breast Cancer. | J Clin Med | 2023 | 37445572 | PubTator, text mining | PubMed |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models. | Cancers (Basel) | 2023 | 37444459 | PubTator, text mining | PubMed |
| Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies. | Cancers (Basel) | 2023 | 37444415 | PubTator, text mining | PubMed |
| Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation. | Cells | 2023 | 37443748 | PubTator, text mining | PubMed |
| Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes. | Res Rep Urol | 2023 | 37441525 | PubTator, text mining | PubMed |
| Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. | Ther Adv Med Oncol | 2023 | 37435563 | PubTator, text mining | PubMed |
| Bioactivity of recombinant humanized monoclonal antibody against HER2 in-vivo and in-vitro and its mechanism of action in ovarian cancer. | Transl Cancer Res | 2023 | 37434690 | PubTator, text mining | PubMed |
| KS-EMPD-1: a novel cell line of primary extramammary Paget's disease. | Hum Cell | 2023 | 37432591 | PubTator, text mining | PubMed |
| PARP inhibitors: enhancing efficacy through rational combinations. | Br J Cancer | 2023 | 37430137 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for urothelial carcinoma. | Urol Oncol | 2023 | 37419845 | PubTator, text mining | PubMed |
| Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires. | Sci Adv | 2023 | 37418532 | PubTator, text mining | PubMed |
| Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer. | Breast Cancer Res Treat | 2023 | 37418031 | PubTator, text mining | PubMed |
| Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. | Mol Cancer | 2023 | 37415164 | PubTator, text mining | PubMed |
| Therapeutic index improvement of antibody-drug conjugates. | MAbs | 2023 | 37408311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4070/papers?page=54